Relation between microalbuminuria and gene mutations in familial Mediterranean fever

Müferet Ergüven1, Can Emeksiz, Murat Deveci

  • 1Department of Pediatrics, Ministry of Health Göztepe Training Hospital, Istanbul, Turkey.

Insights

Patients with familial Mediterranean fever (FMF) show elevated urinary microalbumin/creatinine ratios, indicating early kidney damage. Regular monitoring of microalbuminuria is recommended to prevent FMF-related renal complications.

Area of Science:

  • Nephrology
  • Rheumatology
  • Genetics

Background:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
  • Renal involvement is a potential complication of FMF.
  • Urinary microalbumin is a sensitive marker for early glomerular damage.

Purpose of the Study:

  • To investigate urinary microalbumin levels in FMF patients.
  • To assess the relationship between FMF gene mutations and microalbuminuria.
  • To establish early markers of renal involvement in FMF.

Main Methods:

  • Study included 50 pediatric FMF patients diagnosed by Tel-Hashomer criteria.
  • Evaluated 24-hour urinary microalbumin levels and microalbumin/creatinine ratios.
  • Analyzed FMF gene mutations (M694V, V726A, M680I) and acute phase reactants.

Main Results:

  • FMF patients exhibited significantly higher urinary microalbumin/creatinine ratios compared to controls.
  • No significant differences in microalbumin/creatinine ratios were found among different FMF gene mutation subgroups.
  • Routine renal function tests did not show significant differences between groups.

Conclusions:

  • Elevated urinary microalbumin/creatinine ratio suggests early renal injury in FMF patients.
  • Regular monitoring of microalbuminuria is crucial for early detection and management of renal complications in FMF.
  • Further research may explore the long-term implications of microalbuminuria in FMF.